Ahrens Investment Partners LLC Acelrx Pharmaceuticals Inc Transaction History

Ahrens Investment Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$0.93 - $1.51 $4,650 - $7,550	-5,000 Reduced 7.3%	63,500 $65,000
Q2 2021 Jul 27, 2021	BUY	$1.03 - $1.7 $5,150 - $8,500	5,000 Added 7.87%	68,500 $95,000
Q3 2020 Nov 12, 2020	BUY	$1.01 - $1.81 $2,020 - $3,620	2,000 Added 3.25%	63,500 $90,000
Q4 2019 Feb 13, 2020	BUY	$1.66 - $2.4 $102,090 - $147,600	61,500 New	61,500 $129,000
Q2 2019 Aug 05, 2019	SELL	$2.1 - $3.93 $64,890 - $121,437	-30,900 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$2.35 - $3.83 $72,615 - $118,347	30,900 New	30,900 $108,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Ahrens Investment Partners LLC with notifications on news.